BTTX (OTC)
BETTER THERAPEUTICS INC
$0.000100
+0.000000 (+0.00%)
Prev close: $0.000100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Craig R. Jalbert
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.01M
- Employees
- 54
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-0.15 | $-0.20 | +0.0489 | +24.59% |
|
Jun 2023 (Q2)
|
$-0.24 | $-0.32 | +0.0788 | +24.72% |
|
Mar 2023 (Q1)
|
$-0.39 | $-0.76 | +0.3699 | +48.68% |
|
Dec 2022 (Q4)
|
$-0.37 | $-0.52 | +0.1468 | +28.41% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $29.61M |
| Research and Development | $10.51M |
| Other Operating Expenses | $19.10M |
| Operating Income/Loss | -$29.61M |
| Income/Loss From Continuing Operations After Tax | -$31.57M |
| Income/Loss From Continuing Operations Before Tax | -$31.56M |
| Income Tax Expense/Benefit | $9.00K |
| Interest Expense, Operating | $1.95M |
| Net Income/Loss | -$31.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.15 |
| Diluted Earnings Per Share | -$1.15 |
| Basic Average Shares | 66,061,014 |
| Diluted Average Shares | 93,561,494 |
| Assets | $10.72M |
| Current Assets | $7.35M |
| Prepaid Expenses | $674.00K |
| Other Current Assets | $6.67M |
| Noncurrent Assets | $3.38M |
| Fixed Assets | $102.00K |
| Other Non-current Assets | $3.28M |
| Liabilities | $20.66M |
| Current Liabilities | $12.94M |
| Accounts Payable | $2.31M |
| Wages | $1.89M |
| Other Current Liabilities | $8.74M |
| Noncurrent Liabilities | $7.72M |
| Equity | -$9.94M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$9.94M |
| Liabilities And Equity | $10.72M |
| Net Cash Flow From Operating Activities | -$26.08M |
| Net Cash Flow From Operating Activities, Continuing | -$26.08M |
| Net Cash Flow From Investing Activities | -$1.32M |
| Net Cash Flow From Investing Activities, Continuing | -$1.32M |
| Net Cash Flow From Financing Activities | $11.69M |
| Net Cash Flow From Financing Activities, Continuing | $11.69M |
| Net Cash Flow | -$15.71M |
| Net Cash Flow, Continuing | -$15.71M |
| Comprehensive Income/Loss | -$31.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.57M |
| Other Comprehensive Income/Loss | $0.00 |